
Eric Olson
Examiner (ID: 316, Phone: (571)272-9051 , Office: P/1673 )
| Most Active Art Unit | 1623 |
| Art Unit(s) | 1693, 1673, 1623 |
| Total Applications | 1758 |
| Issued Applications | 971 |
| Pending Applications | 175 |
| Abandoned Applications | 632 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 17851812
[patent_doc_number] => 20220281854
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-09-08
[patent_title] => COMBINATION THERAPY FOR TREATING CANCER
[patent_app_type] => utility
[patent_app_number] => 17/751153
[patent_app_country] => US
[patent_app_date] => 2022-05-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 38779
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 291
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17751153
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/751153 | COMBINATION THERAPY FOR TREATING CANCER | May 22, 2022 | Abandoned |
Array
(
[id] => 18065743
[patent_doc_number] => 20220396830
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-12-15
[patent_title] => BIOLUMINESCENT DETECTION OF DNA SYNTHESIS
[patent_app_type] => utility
[patent_app_number] => 17/744255
[patent_app_country] => US
[patent_app_date] => 2022-05-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 17914
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -15
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17744255
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/744255 | BIOLUMINESCENT DETECTION OF DNA SYNTHESIS | May 12, 2022 | Pending |
Array
(
[id] => 18065743
[patent_doc_number] => 20220396830
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-12-15
[patent_title] => BIOLUMINESCENT DETECTION OF DNA SYNTHESIS
[patent_app_type] => utility
[patent_app_number] => 17/744255
[patent_app_country] => US
[patent_app_date] => 2022-05-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 17914
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -15
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17744255
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/744255 | BIOLUMINESCENT DETECTION OF DNA SYNTHESIS | May 12, 2022 | Pending |
Array
(
[id] => 17790445
[patent_doc_number] => 20220249536
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-08-11
[patent_title] => ANTIBODY DRUG CONJUGATES
[patent_app_type] => utility
[patent_app_number] => 17/730924
[patent_app_country] => US
[patent_app_date] => 2022-04-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 27723
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -25
[patent_words_short_claim] => 188
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17730924
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/730924 | Antibody drug conjugates | Apr 26, 2022 | Issued |
Array
(
[id] => 17807418
[patent_doc_number] => 20220259253
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-08-18
[patent_title] => CD73 INHIBITORS
[patent_app_type] => utility
[patent_app_number] => 17/722513
[patent_app_country] => US
[patent_app_date] => 2022-04-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 74599
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -123
[patent_words_short_claim] => 1087
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17722513
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/722513 | CD73 INHIBITORS | Apr 17, 2022 | Abandoned |
Array
(
[id] => 19650016
[patent_doc_number] => 12171776
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-12-24
[patent_title] => Methods for treatment and prophylaxis of HIV and AIDS
[patent_app_type] => utility
[patent_app_number] => 17/658547
[patent_app_country] => US
[patent_app_date] => 2022-04-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 9805
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 40
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17658547
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/658547 | Methods for treatment and prophylaxis of HIV and AIDS | Apr 7, 2022 | Issued |
Array
(
[id] => 17704962
[patent_doc_number] => 20220204968
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-06-30
[patent_title] => LYSIS, BINDING AND/OR WASH REAGENT FOR ISOLATING AND/OR PURIFYING NUCLEIC ACIDS
[patent_app_type] => utility
[patent_app_number] => 17/695270
[patent_app_country] => US
[patent_app_date] => 2022-03-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10063
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -13
[patent_words_short_claim] => 62
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17695270
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/695270 | LYSIS, BINDING AND/OR WASH REAGENT FOR ISOLATING AND/OR PURIFYING NUCLEIC ACIDS | Mar 14, 2022 | Pending |
Array
(
[id] => 18109631
[patent_doc_number] => 20230002511
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-01-05
[patent_title] => HIGH-VISCOSITY LITHIUM CARBOXYMETHYL CELLULOSE AND PREPARATION METHOD THEREFOR AND APPLICATION THEREOF
[patent_app_type] => utility
[patent_app_number] => 17/681971
[patent_app_country] => US
[patent_app_date] => 2022-02-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5124
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => 0
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17681971
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/681971 | High-viscosity lithium carboxymethyl cellulose and preparation method therefor and application thereof | Feb 27, 2022 | Issued |
Array
(
[id] => 17670944
[patent_doc_number] => 20220184111
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-06-16
[patent_title] => METHODS FOR MODULATING CHEMOTHERAPEUTIC CYTOTOXICITY
[patent_app_type] => utility
[patent_app_number] => 17/682655
[patent_app_country] => US
[patent_app_date] => 2022-02-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 22680
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 94
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17682655
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/682655 | METHODS FOR MODULATING CHEMOTHERAPEUTIC CYTOTOXICITY | Feb 27, 2022 | Abandoned |
Array
(
[id] => 17687687
[patent_doc_number] => 20220194979
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-06-23
[patent_title] => METHOD FOR PREPARING DELPHINIUM ACYLATED ANTHOCYANIN
[patent_app_type] => utility
[patent_app_number] => 17/674860
[patent_app_country] => US
[patent_app_date] => 2022-02-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4226
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -6
[patent_words_short_claim] => 346
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17674860
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/674860 | Method for preparing delphinium acylated anthocyanin | Feb 17, 2022 | Issued |
Array
(
[id] => 18091303
[patent_doc_number] => 20220409644
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-12-29
[patent_title] => ANIMAL THERAPEUTIC AND FEED COMPOSITIONS AND METHODS OF USE
[patent_app_type] => utility
[patent_app_number] => 17/674032
[patent_app_country] => US
[patent_app_date] => 2022-02-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 50421
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -14
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17674032
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/674032 | ANIMAL THERAPEUTIC AND FEED COMPOSITIONS AND METHODS OF USE | Feb 16, 2022 | Abandoned |
Array
(
[id] => 17642270
[patent_doc_number] => 20220170008
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-06-02
[patent_title] => POLYNUCLEOTIDE CAPTURE MATERIALS, AND SYSTEMS USING SAME
[patent_app_type] => utility
[patent_app_number] => 17/674177
[patent_app_country] => US
[patent_app_date] => 2022-02-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13472
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17674177
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/674177 | POLYNUCLEOTIDE CAPTURE MATERIALS, AND SYSTEMS USING SAME | Feb 16, 2022 | Pending |
Array
(
[id] => 17642270
[patent_doc_number] => 20220170008
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-06-02
[patent_title] => POLYNUCLEOTIDE CAPTURE MATERIALS, AND SYSTEMS USING SAME
[patent_app_type] => utility
[patent_app_number] => 17/674177
[patent_app_country] => US
[patent_app_date] => 2022-02-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13472
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17674177
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/674177 | POLYNUCLEOTIDE CAPTURE MATERIALS, AND SYSTEMS USING SAME | Feb 16, 2022 | Pending |
Array
(
[id] => 19441229
[patent_doc_number] => 12091470
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-09-17
[patent_title] => Use of poly alpha-1,3-glucan ethers as viscosity modifiers
[patent_app_type] => utility
[patent_app_number] => 17/667707
[patent_app_country] => US
[patent_app_date] => 2022-02-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 36004
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 43
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17667707
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/667707 | Use of poly alpha-1,3-glucan ethers as viscosity modifiers | Feb 8, 2022 | Issued |
Array
(
[id] => 17865361
[patent_doc_number] => 20220288096
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-09-15
[patent_title] => COMPOSITIONS AND METHODS FOR TREATING AN AGGREGATION DISEASE OR DISORDER
[patent_app_type] => utility
[patent_app_number] => 17/588507
[patent_app_country] => US
[patent_app_date] => 2022-01-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10962
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17588507
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/588507 | COMPOSITIONS AND METHODS FOR TREATING AN AGGREGATION DISEASE OR DISORDER | Jan 30, 2022 | Abandoned |
Array
(
[id] => 17593483
[patent_doc_number] => 20220143056
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-05-12
[patent_title] => METHODS AND THERAPIES FOR TREATING ATHEROSCLEROSIS AND/OR HYPERLIPIDEMIA USING OLIGOSACCHARIDES
[patent_app_type] => utility
[patent_app_number] => 17/584129
[patent_app_country] => US
[patent_app_date] => 2022-01-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11647
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 62
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17584129
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/584129 | METHODS AND THERAPIES FOR TREATING ATHEROSCLEROSIS AND/OR HYPERLIPIDEMIA USING OLIGOSACCHARIDES | Jan 24, 2022 | Pending |
Array
(
[id] => 17593483
[patent_doc_number] => 20220143056
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-05-12
[patent_title] => METHODS AND THERAPIES FOR TREATING ATHEROSCLEROSIS AND/OR HYPERLIPIDEMIA USING OLIGOSACCHARIDES
[patent_app_type] => utility
[patent_app_number] => 17/584129
[patent_app_country] => US
[patent_app_date] => 2022-01-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11647
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 62
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17584129
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/584129 | METHODS AND THERAPIES FOR TREATING ATHEROSCLEROSIS AND/OR HYPERLIPIDEMIA USING OLIGOSACCHARIDES | Jan 24, 2022 | Pending |
Array
(
[id] => 20192217
[patent_doc_number] => 20250268927
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2025-08-28
[patent_title] => SYNBIOTIC TREATMENT REGIMENS
[patent_app_type] => utility
[patent_app_number] => 18/261012
[patent_app_country] => US
[patent_app_date] => 2022-01-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 44834
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18261012
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/261012 | SYNBIOTIC TREATMENT REGIMENS | Jan 11, 2022 | Pending |
Array
(
[id] => 20192217
[patent_doc_number] => 20250268927
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2025-08-28
[patent_title] => SYNBIOTIC TREATMENT REGIMENS
[patent_app_type] => utility
[patent_app_number] => 18/261012
[patent_app_country] => US
[patent_app_date] => 2022-01-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 44834
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18261012
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/261012 | SYNBIOTIC TREATMENT REGIMENS | Jan 11, 2022 | Pending |
Array
(
[id] => 19098302
[patent_doc_number] => 20240117530
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-04-11
[patent_title] => Continuous Dissolution of a Cellulose Derivative
[patent_app_type] => utility
[patent_app_number] => 18/270241
[patent_app_country] => US
[patent_app_date] => 2021-12-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11581
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -33
[patent_words_short_claim] => 78
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18270241
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/270241 | Continuous Dissolution of a Cellulose Derivative | Dec 30, 2021 | Pending |